Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

July 27, 2021

Study Completion Date

July 27, 2021

Conditions
Pharmacokinetics
Interventions
DRUG

gadopiclenol

administration by intravenous (IV) bolus injection at 2 mL/s rate without dilution, followed by a saline flush of at least 5 mL at the same rate to ensure complete injection of the contrast agent.The gadopiclenol administration is performed by power injecto

DRUG

Placebo

intravenous (IV) bolus injection at 2 mL/s, followed by a saline flush of at least 5 mL to be in the same conditions as for gadopiclenol administration.The gadopiclenol administration is performed by power injector

Trial Locations (1)

Unknown

Hataka clinic, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT04906005 - Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers | Biotech Hunter | Biotech Hunter